Det anvendes til enzymsubstitutionsbehandling hos patienter med Mucopolysaccharidose VI (MPS VI; Maroteaux- Lamy syndrom, en aflejringssygdom, hvor niveauet af N- acetylgalactosamine 4- sulfatase enzymaktivitet mangler eller er lavere end normalt.
It is used for enzyme replacement therapy in Mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy syndrome), a storage disorder where the level of N- acetylgalactosamine 4-sulfatase enzyme activity is absent or lower than normal.